Recent Progress in the Diagnosis and Treatment of Ovarian Cancer

Por Jelovac, Danijela, Armstrong, Deborah K.
Publicado em 2011

Role of Farletuzumab in Epithelial Ovarian Carcinoma

Por Jelovac, Danijela, Armstrong, Deborah K.
Publicado em 2012

VALIDATION OF FACT/GOG-AD SUBSCALE FOR OVARIAN CANCER-RELATED ABDOMINAL DISCOMFORT: A GYNECOLOGIC ONCOLOGY GROUP STUDY

Por Wenzel, Lari, Huang, Helen Q., Cella, David, Walker, Joan L., Armstrong, Deborah K.
Publicado em 2008

Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Por Havrilesky, Laura J., Alvarez Secord, Angeles, Darcy, Kathleen M., Armstrong, Deborah K., Kulasingam, Shalini
Publicado em 2008

A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemothe...

Por Krivak, Thomas C., Tian, Chunqiao, Rose, G. Scott, Armstrong, Deborah K., Maxwell, G. Larry
Publicado no Gynecol Oncol (2009)

A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology group study

Por Armstrong, Deborah K., Bookman, Michael A., McGuire, William, Bristow, Robert E., Schilder, Jeanne M.
Publicado em 2007

Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancer

Por Gross, Amy L., May, Betty J., Axilbund, Jennifer E., Armstrong, Deborah K., Roden, Richard B. S., Visvanathan, Kala
Publicado no Cancer Epidemiol Biomarkers Prev (2015)

Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer(,,)

Por Kim, Kenneth H., Jelovac, Danijela, Armstrong, Deborah K., Schwartz, Benjamin, Weil, Susan C., Schweizer, Charles, Alvarez, Ronald D.
Publicado no Gynecol Oncol (2015)

The Association Between Quality of Life Domains and Overall Survival in Ovarian Cancer Patients During Adjuvant Chemotherapy: A Gynecologic Oncology Group Study

Por von Gruenigen, Vivian E., Huang, Helen Q., Gil, Karen M., Frasure, Heidi E., Armstrong, Deborah K., Wenzel, Lari B.
Publicado em 2011

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study()

Por Landrum, Lisa M., Java, James, Mathews, Cara A., Lanneau, Grainger S., Copeland, Larry J., Armstrong, Deborah K., Walker, Joan L.
Publicado no Gynecol Oncol (2013)

Survival in Women With Grade 1 Serous Ovarian Carcinoma

Por Fader, Amanda Nickles, Java, James, Ueda, Stefanie, Bristow, Robert E., Armstrong, Deborah K., Bookman, Michael A., Gershenson, David M.
Publicado no Obstet Gynecol (2013)

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Por Tewari, Devansu, Java, James J., Salani, Ritu, Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas, Monk, Bradley J., Chan, John K.
Publicado no J Clin Oncol (2015)

Phase II Trial of Cetuximab and Carboplatin in Relapsed Platinum-Sensitive Ovarian Cancer and Evaluation of Epidermal Growth Factor Receptor Expression: A Gynecologic Oncology Grou...

Por Secord, Angeles Alvarez, Blessing, John A., Armstrong, Deborah K., Rodgers, William H., Miner, Zoe, Barnes, Mack N., Lewandowski, George, Mannel, Robert S.
Publicado em 2008

CA-125 Change Following Chemotherapy in Prediction of Treatment Outcome among Advanced Mucinous and Clear Cell Epithelial Ovarian Cancers: A Gynecologic Oncology Group Study

Por Tian, Chunqiao, Markman, Maurie, Zaino, Richard, Ozols, Robert F., McGuire, William P., Muggia, Franco M., Rose, Peter G., Spriggs, David, Armstrong, Deborah K.
Publicado em 2009

Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats

Por Sharrow, Allison C, Ronnett, Brigitte M, Thoburn, Christopher J, Barber, James P, Giuntoli, Robert L, Armstrong, Deborah K, Jones, Richard J, Hess, Allan D
Publicado em 2010

Assessment of Factors that Contribute to Decreased Quality of Life in Gynecologic Oncology Group Ovarian Cancer Trials

Por von Gruenigen, Vivian E., Huang, Helen Q., Gil, Karen M., Gibbons, Heidi E., Monk, Bradley J., Rose, Peter G., Armstrong, Deborah K., Cella, David, Wenzel, Lari
Publicado em 2009

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study

Por von Gruenigen, Vivian E., Huang, Helen Q., Gil, Karen M., Gibbons, Heidi E., Monk, Bradley J., Rose, Peter G., Armstrong, Deborah K., Cella, David, Wenzel, Lari
Publicado em 2010

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study(, )

Por Fader, Amanda Nickles, Java, James, Krivak, Thomas C., Bristow, Robert E., Tergas, Ana I., Bookman, Michael A., Armstrong, Deborah K., Tanner, Edward J., Gershenson, David M.
Publicado no Gynecol Oncol (2013)

PROGNOSTIC VALUE OF PRETREATMENT CA-125 IN ADVANCED OVARIAN CARCINOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY

Por Zorn, Kristin K., Tian, Chunqiao, McGuire, William P., Hoskins, William J., Markman, Maurie, Muggia, Franco M., Rose, Peter G., Ozols, Robert F., Spriggs, David, Armstrong, Deborah K.
Publicado em 2009

Pre-Treatment Tumor Expression of ERCC1 in Women with Advanced Stage Epithelial Ovarian Cancer is Not Predictive of Clinical Outcomes: A Gynecologic Oncology Group Study

Por Rubatt, Jennifer M., Darcy, Kathleen M., Tian, Chunqiao, Muggia, Franco, Dhir, Rajiv, Armstrong, Deborah K., Bookman, Michael A., Niedernhofer, Laura J., Deloia, Julie, Birrer, Michael, Krivak, Thomas Carl
Publicado em 2012